Clinical trials in Rock Hill, SC

25 recruiting studies have a site in or near Rock Hill, SC, South Carolina.

Top conditions here

All conditions

Showing 25 of 25 studies

RecruitingPhase 2NCT07610395

Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD

Sponsor: Altesa Biosciences, Inc.

Anderson, SC · Rock Hill, SC · Spartanburg, SC · +34 more sites

RecruitingPhase 3NCT06307665

Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma

Sponsor: AstraZeneca

Charleston, SC · Rock Hill, SC · +118 more sites

RecruitingPhase 2NCT06977581

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma

Sponsor: Pfizer

Rock Hill, SC · +35 more sites

RecruitingPhase not listedNCT07556159

A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice

Sponsor: Sanofi

Rock Hill, SC · +62 more sites

RecruitingPhase 3NCT03678025

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Sponsor: SWOG Cancer Research Network

Boiling Springs, SC · Charleston, SC · Greenville, SC · +331 more sites

RecruitingPhase 3NCT07359846

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)

Sponsor: Generate Biomedicines

Rock Hill, SC · +20 more sites

RecruitingPhase 2NCT07323654

A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma

Sponsor: Kymera Therapeutics, Inc.

North Charleston, SC · Rock Hill, SC · +32 more sites

RecruitingPhase 3NCT06959095

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

Sponsor: GlaxoSmithKline

Greenville, SC · Rock Hill, SC · +40 more sites

RecruitingPhase 2NCT07684820

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

Sponsor: Expedition Therapeutics, Inc

Rock Hill, SC · +21 more sites

RecruitingPhase 2NCT06932263

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

Sponsor: AstraZeneca

Rock Hill, SC · +63 more sites

RecruitingPhase 2 / Phase 3NCT07196722

A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Sponsor: Janssen Research & Development, LLC

Rock Hill, SC · +60 more sites

RecruitingPhase 3NCT07196748

A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

Sponsor: Janssen Research & Development, LLC

Rock Hill, SC · +55 more sites

RecruitingPhase 2NCT07459634

A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC

Sponsor: Jazz Pharmaceuticals

Rock Hill, SC · +4 more sites

RecruitingPhase not listedNCT05059444

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

Sponsor: Guardant Health, Inc.

Myrtle Beach, SC · Rock Hill, SC · +31 more sites

RecruitingPhase 3NCT06252649

Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation

Sponsor: Amgen

Rock Hill, SC · +25 more sites

RecruitingPhase 3NCT06883305

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Sponsor: AstraZeneca

Rock Hill, SC · +72 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Bluffton, SC · Boiling Springs, SC · Charleston, SC · +1223 more sites

RecruitingPhase 2 / Phase 3NCT07363694

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Sponsor: Pfizer

Columbia, SC · Gaffney, SC · Rock Hill, SC · +58 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Bluffton, SC · Boiling Springs, SC · Charleston, SC · +825 more sites

RecruitingPhase 3NCT06748222

E-Mindfulness Approaches for Living After Breast Cancer

Sponsor: NRG Oncology

Beaufort, SC · Boiling Springs, SC · Charleston, SC · +378 more sites

RecruitingPhase 3NCT07177339

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Sponsor: GlaxoSmithKline

Greenville, SC · Rock Hill, SC · +40 more sites

RecruitingPhase 2NCT07532265

A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma

Sponsor: Kinaset Therapeutics Inc

Rock Hill, SC · +13 more sites

RecruitingPhase 3NCT06592924

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

Sponsor: Canadian Cancer Trials Group

Charleston, SC · Rock Hill, SC · +372 more sites

RecruitingPhase 1NCT07290036

A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults

Sponsor: UCB Biopharma SRL

Rock Hill, SC · +29 more sites

RecruitingPhase 3NCT04852887

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Sponsor: NRG Oncology

Bluffton, SC · Charleston, SC · Florence, SC · +809 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.